Suven Life Sciences (SUVEN) Share Price Rises 8.2% Today

Suven Life Sciences Share Price is trading at Rs 306.90, up 8.2% from the previous close, with market capitalisation at Rs 8,021.95 Cr. The move places SUVEN among the day’s notable gainers in the Indian stock market, although according to Univest data, the price event is confirmed, but no company-specific catalyst is established. The latest Univest figures show the share price moved higher within a relatively tight intraday range, and that makes the price action relevant for investors tracking Suven Life Sciences Share Price Today, Suven Life Sciences Stock News and broader Stocks in News coverage. In the opening trade, the stock was already above the previous close and continued to move upward through the morning session. For readers asking why is Suven Life Sciences rising today, the verified data supports the move itself, while the next sections place the share price rise alongside valuation, fundamentals and sector context.

Suven Life Sciences Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 306.9
Previous Close	Rs 283.65
Today's Move	Rs 23.25 (+8.2%)
Open	Rs 287.85
High	Rs 308.05
Low	Rs 286
Market Capitalisation	Rs 8,021.95 crore
Market Cap Category	Mid Cap

Suven Life Sciences Ltd. (SUVEN) rose to Rs 306.9 from the previous close of Rs 283.65, a move of Rs 23.25 or 8.2%. The stock opened at Rs 287.85, reached a high of Rs 308.05, recorded a low of Rs 286.

Suven Life Sciences Share Price is higher by Rs 23.25 from the previous close, and the stock is trading at Rs 306.90 after opening at Rs 287.85. During the morning session, the share price touched a high of Rs 308.05 and a low of Rs 286.00, which shows that the move stayed contained inside a defined range even as SUVEN stayed in positive territory. This is a clear price rise for Suven Life Sciences Share Price Today, with the current level sitting close to the day’s high and above the opening print. For readers following Suven Life Sciences Stock News, the key point is simple: the share price update is real, the move is visible, and the latest Univest figures do not establish a fresh company-specific trigger. That makes price action the starting point, while the next layer is the company’s financial and valuation backdrop.

Suven Life Sciences Ltd. (SUVEN) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 8,021.95 crore
P/B Ratio	14.39x
ROE	-101.8%
ROCE	-78.71%
EPS	Rs -12.47
Book Value Per Share	Rs 19.71
Dividend Yield	0%

Suven Life Sciences Ltd. (SUVEN) fundamental metrics show P/B 14.39x, ROE -101.8%, ROCE -78.71%. These ratios show where the company stands today and are not a call to buy or sell.

Suven Life Sciences Ltd. has a market capitalisation of Rs 8,021.95 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/B at 14.39x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of -101.8% and ROCE of -78.71%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs -12.47, book value per share of Rs 19.71, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.35x, median ROE of 11.61%, median ROCE of 13.46%. Together they describe the fundamental backdrop without implying a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Benchmark Median P/E	31.35x
Benchmark Average P/E	46.92x
Benchmark P/E Range	3.13x to 654.72x
Company P/B Ratio	14.39x
Benchmark Median P/B	2.84x
Company ROE	-101.8%
Benchmark Median ROE	11.61%
Company ROCE	-78.71%
Benchmark Median ROCE	13.46%
Company Market Capitalisation	Rs 8,021.95 crore
Benchmark Median Market Cap	Rs 827.89 crore

Suven Life Sciences Ltd. (SUVEN) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Suven Life Sciences Ltd. (SUVEN) has a ROE of -101.8%, which is below the benchmark median of 11.61%, a difference of -976.83%. Suven Life Sciences Ltd. (SUVEN) has a ROCE of -78.71%, which is below the benchmark median of 13.46%, a difference of -684.77%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,24,466.35	34.69	4.85	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,46,222.11	81.95	13.57	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,76,300.5	80.12	19.47	26.76	19.27
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,12,817.68	24.84	4.16	19.69	21.39
Laurus Labs Ltd.	LAURUSLABS	1,10,823.44	100.61	19.51	18.31	18.2

Its ROE of -101.8% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at -78.71% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Suven Life Sciences Ltd. (SUVEN) has a market capitalisation of Rs 8,021.95 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Suven Life Sciences

• Suven Life Sciences Share Price is up 8.2% today, with the stock trading at Rs 306.90 and staying near the day’s high.
• The latest Univest figures show no company-specific catalyst has been established, so the price rise is being tracked on verified price action.
• Suven Life Sciences Fundamental Analysis shows EPS of Rs -12.47, ROE of -101.8% and ROCE of -78.71%, which adds valuation context.
• Suven Life Sciences Market Cap of Rs 8,021.95 Cr keeps the company above the industry median but below the industry average.
• In the sector snapshot, Suven Life Sciences Share Price sits well above the industry median P/B and below several large Healthcare peers on scale.

About Suven Life Sciences

Suven Life Sciences Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company is followed by investors for its position within Indian pharma and for how Suven Life Sciences Share Price reflects the market’s view of its business and financial structure. In a sector where peers range from large diversified pharma names to specialty-focused companies, Suven Life Sciences Stock Performance is usually assessed with a close eye on valuation, earnings quality and return ratios. The current numbers show a company with market capitalisation of Rs 8,021.95 Cr, a P/B ratio of 14.39 and negative return ratios, which makes the financial profile central to any Suven Life Sciences Stock Analysis. For readers tracking Suven Life Sciences Company News, the business context is best understood through its sector position and financial ratios rather than through unsupported assumptions about near-term operating momentum.

Frequently Asked Questions

Why is Suven Life Sciences Share Price rising today?

Ans. Suven Life Sciences Share Price is rising today by 8.2% to Rs 306.90. According to Univest data, the price event is confirmed, but no company-specific catalyst is established, so the move should be read from the verified price action.

What is Suven Life Sciences Share Price today?

Ans. Suven Life Sciences Share Price is trading at Rs 306.90, up Rs 23.25 from the previous close of Rs 283.65. The stock has moved between Rs 286.00 and Rs 308.05 during the morning session.

What is the market capitalisation of Suven Life Sciences?

Ans. Suven Life Sciences has a market capitalisation of Rs 8,021.95 Cr. In the same industry benchmark, that places it above the median market cap of Rs 827.89 Cr and below the average of Rs 13,758.85 Cr.

How does Suven Life Sciences Share Price compare with peers?

Ans. Suven Life Sciences Share Price sits on a smaller market cap base than Sun Pharma, Divi’s Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences and Laurus Labs. Its P/B is higher than some peers and its return ratios are negative.

What does Suven Life Sciences Fundamental Analysis show?

Ans. Suven Life Sciences Fundamental Analysis shows EPS of Rs -12.47, book value of Rs 19.71, P/B of 14.39, ROE of -101.8% and ROCE of -78.71%. Those figures frame the share price rise in valuation terms.

Is Suven Life Sciences expensive versus the sector?

Ans. Suven Life Sciences Share Price carries a P/B of 14.39, which is far above the sector median P/B of 2.84 and sector average of 4.25. On that measure, the stock screens richer than the benchmark group.

Does Suven Life Sciences pay a dividend?

Ans. The latest Univest figures show dividend yield of 0% for Suven Life Sciences. That means the current Suven Life Sciences Share Price is not being supported by a dividend yield component in the present comparison set.

What sector does Suven Life Sciences belong to?

Ans. Suven Life Sciences belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. That context matters because Suven Life Sciences Share Price is being compared with peers that also operate in the same industry group.

Track Suven Life Sciences Share Price on Univest

Use Suven Life Sciences Ltd. (SUVEN) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

You can track Suven Life Sciences Share Price on Univest for live price movement, market cap, fundamental ratios, 52-week levels and sector insights. Univest also helps readers follow Suven Life Sciences Share Price Today alongside related stock news, valuation context and peer comparison in one place. If you are monitoring SUVEN through the trading day, Univest keeps the share price update and the broader company overview together for easier review.